Clinical trials recruiting for ESR1 Gene Mutation
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Elacestrant | 3 |
| Auxiliary Medicinal Product - Dexamethasone | 1 |
| Auxiliary Medicinal Product - Luteinizing hormone-releasing hormone (LHRH) analogues | 1 |
| Capecitabine | 1 |
| Everolimus | 1 |
| Tamoxifen | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
- FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
- PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
Related conditions
Trials recruiting for ESR1 Gene Mutation often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for ESR1 Gene Mutation trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.